Mimedx (MDXG) Net Margin Growth (1y) (2012 - 2024)
Mimedx (MDXG) Net Margin Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4,362.00 |
| Sep 30, 2024 | 72.00 |
| Jun 30, 2024 | 1,095.00 |
| Mar 31, 2024 | 1,576.00 |
| Dec 31, 2023 | 4,069.00 |
| Sep 30, 2023 | 2,357.00 |
| Jun 30, 2023 | 2,794.00 |
| Mar 31, 2023 | 1,544.00 |
| Dec 31, 2022 | 1,369.00 |
| Sep 30, 2022 | -871.00 |
| Jun 30, 2022 | -1,388.00 |
| Mar 31, 2022 | -408.00 |
| Dec 31, 2021 | 2,359.00 |
| Sep 30, 2021 | 7,464.00 |
| Jun 30, 2021 | 1,097.00 |
| Mar 31, 2021 | -862.00 |
| Dec 31, 2020 | -1,656.00 |
| Sep 30, 2020 | -9,477.00 |
| Jun 30, 2020 | 974.00 |
| Mar 31, 2020 | 1,213.00 |